Where medical-technology value is being created
The returns in medtech are shifting. We map where capital is finding durable value, and which segments are crowded rather than compelling.
Read
Insights Strategy for medical growth
Perspectives on medical-technology growth
Short, plain views for the people who fund and build medical technology. Where value is being created, how ventures and ecosystems scale, and how to de-risk the path from capital to market.
01 Recent thinking
Themes for investors and institutions
A boutique strategy view on medtech: where to invest, how to build and scale, and how to read the market before you commit.
Building a medtech ecosystem from zero
Governments and development agencies want medtech capability, not just a single plant. We set out the building blocks and the sequence that holds.
ReadSequencing entry across the EU and US
Which market first is a strategic call, not an afterthought. We weigh the trade-offs in timing, evidence and reimbursement that shape the order.
ReadRegulation as a growth lever, not a gate
Handled early, regulation builds value and trust. We frame it as a strategic asset to plan around, not a hurdle to clear at the end.
ReadWhat to look for in a medtech investment
The pitch rarely shows the real risk. We share the signals we test in diligence, from regulatory exposure to the credibility of the path to scale.
ReadWhat actually scales a medtech venture
Growth stalls for predictable reasons. We name the few things that move a venture from a working product to a business that compounds.
ReadIllustrative themes, drawn from our work with investors and institutions, kept high-level by design and updated as the market moves.
The next step
Weighing a move in medtech?
If you are deciding where to invest, how to build, or how to scale a medical-technology venture, talk to us. We will give you a candid read on the opportunity and the route to growth.